Mohannad Emad Qazzaz

Mohannad Emad Qazzaz

Auto-generated profile, based on publicly available information

Mohannad Emad Qazzaz

Department of Pharmacognosy and Medicinal Plants, College of Pharmacy, University of Mosul, Mosul, Iraq

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in Cancer Letters
Verified
Journal Article
Closed access
MQMohannad E. Qazzaz
Mohannad E. Qazzaz
VRVijay J. Raja
Vijay J. Raja
KLKuan-Hon Lim
Kuan-Hon Lim
TKToh-Seok Kam
Toh-Seok Kam
Jong Bong LeeJong Bong Lee
Jong Bong Lee
TBTracey Bradshaw
Tracey Bradshaw

14 April 2020 in Pharmacology
Verified
Journal Article
Closed access
MAMohammed Najim Abed
Mohammed Najim Abed
FAFawaz A. Alassaf
Fawaz A. Alassaf
MJMahmood H.M. Jasim
Mahmood H.M. Jasim
MAMohanad Alfahad
Mohanad Alfahad
MQMohannad E. Qazzaz
Mohannad E. Qazzaz
Introduction: Peptic lesions usually develop when there is an imbalance between aggressive drivers and gastro-protective mediators that guard the lining of the gastrointestinal tract. The most crucial of these mediators are antioxidants, whose loss may predispose to oxidative stress, which is believed to be the main aggravator of several diseases including peptic ulcer. Proton pump inhibitors (PPIs) are drugs that are highly effective and widely used for therapeutic management of peptic disorders through inhibition of gastric acid secretion. In spite of this, oxidative damage may continue to be a major issue that can predispose to future lesions. Objective: The present study is designed to explore the possible antioxidant capability of different PPIs, including omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole, in an aim to suggest an agent that, in addition to its acid-suppression properties, can provide antioxidant profit. Methods: The antioxidant activity of different PPIs was evaluated calorimetrically to test the ability of each drug to quench oxygen free radical, using the well-known stable free radical α,α-diphenyl-β-picrylhydrazyl (DPPH), and compared to ascorbic acid (AA; vitamin C). The measurements were performed using a spectrophotometer at 517 nm. Results: All the studied drugs reduced DPPH, but to different extents. However, omeprazole and esomeprazole showed the highest ability to scavenge free radicals (50% inhibitory concentrations [IC50s] of the percentage for free radical scavenging activity are 18.7 ± 5.7 and 18.7 ± 5.7, respectively, and the AA equivalents are 83,772 ± 11,887 and 81,732 ± 8,523 mg AA/100 g, respectively). Conversely, lansoprazole, pantoprazole, and rabeprazole might be having no role in this story (IC50s of the percentage for free radical scavenging activity are 49.3 ± 3.1, 49 ± 9.4, and 40.7 ± 7.2, respectively, and the AA equivalents are 30,458 ± 3,884, 32,222 ± 10,377, and 37,876 ± 8,816 mg AA/100 g, respectively). Conclusion: Thus, omeprazole and esomeprazole may confer a significant dual action in gastrointestinal protection by providing potent antioxidant properties in addition to their major role as acid-suppression agents. However, further studies are essential to elucidate the mechanism behind the difference between the drugs of the same class.

1 March 2018 in Fitoterapia
Verified
Journal Article
Closed access
MBMohammed Khaled Bin Break
Mohammed Khaled Bin Break
MHMd Shahadat Hossan
Md Shahadat Hossan
YKYivonn Khoo
Yivonn Khoo
MQMohannad Emad Qazzaz
Mohannad Emad Qazzaz
MAMohammed Z.K. Al-Hayali
Mohammed Z.K. Al-Hayali
TKTeng Jin Khoo
Teng Jin Khoo

1 March 2016 in Phytochemistry Letters
Verified
Journal Article
Closed access
VYVeronica Alicia Yap
Veronica Alicia Yap
MQMohannad E. Qazzaz
Mohannad E. Qazzaz
VRVijay J. Raja
Vijay J. Raja
TBTracey D. Bradshaw
Tracey D. Bradshaw
HLHwei-San Loh
Hwei-San Loh
KLKuan-Hon Lim
Kuan-Hon Lim

31 May 2024 in Journal of Bone Metabolism
Verified
Journal Article
Open access
PDF file
MAMohammed Najim Abed
Mohammed Najim Abed
FAFawaz A. Alassaf
Fawaz A. Alassaf
MQMohannad E. Qazzaz
Mohannad E. Qazzaz
Vitamin D (ViD), plays an important role in calcium absorption and bone mineralization, is associated with bone mineral density. Severe deficiency in ViD has long been linked to conditions such as rickets in children and osteomalacia in adults, revealing its substantial role in skeletal health. Additionally, investigations show an existing interconnection between ViD and insulin resistance (Ins-R), especially in patients with type 2 diabetes mellitus (T2DM). Obesity, in conjunction with Ins-R, may augment the risk of osteoporosis and deterioration of skeletal health. This review aims to examine recent studies on the interplay between ViD, Ins-R, obesity, and their impact on skeletal health, to offer insights into potential therapeutic strategies. Cochrane Library, Google Scholar, and Pubmed were searched to investigate relevant studies until December 2023. Current research demonstrates ViD’s impact on pancreatic β-cell function, systemic inflammation, and insulin action regulation. Our findings highlight an intricate association between ViD, Ins-R, obesity, and skeletal health, providing a perspective for the prevention and/or treatment of skeletal disorders in patients with obesity, Ins-R, and T2DM.

13 July 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
CSChristopher J. Smedley
Christopher J. Smedley
PSPaul A. Stanley
Paul A. Stanley
MQMohannad E. Qazzaz
Mohannad E. Qazzaz
APAndrea E. Prota
Andrea E. Prota
NONatacha Olieric
Natacha Olieric
JMJohn Edward Moses
John Edward Moses
The jerantinine family of Aspidosperma indole alkaloids from Tabernaemontana corymbosa are potent microtubule-targeting agents with broad spectrum anticancer activity. The natural supply of these precious metabolites has been significantly disrupted due to the inclusion of T. corymbosa on the endangered list of threatened species by the International Union for Conservation of Nature. This report describes the asymmetric syntheses of (−)-jerantinines A and E from sustainably sourced (−)-tabersonine, using a straight-forward and robust biomimetic approach. Biological investigations of synthetic (−)-jerantinine A, along with molecular modelling and X-ray crystallography studies of the tubulin—(−)-jerantinine B acetate complex, advocate an anticancer mode of action of the jerantinines operating via microtubule disruption resulting from binding at the colchicine site. This work lays the foundation for accessing useful quantities of enantiomerically pure jerantinine alkaloids for future development.